To compare the degree of patient comfort during awake fiberoptic intubation using dexmedetomidine with lignocaine versus plain lignocaine
- Conditions
- Health Condition 1: O- Medical and Surgical
- Registration Number
- CTRI/2021/10/037069
- Lead Sponsor
- Himalayan Institute of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
1. Patients with anticipated difficult intubation.
2. Patients aged between 18 - 65 years of both genders who upon being explained the procedure are willing to participate in the study.
1. Patients who are uncooperative to awake fiberoptic intubation.
2. Patients allergic to lignocaine, xylometazoline, phenylephrine or glycopyrrolate.
3. Patients with uncontrolled diabetes mellitus, hypertension or heart block.
4. Patients who are on beta-blockers.
5. Patients with a history of bleeding diathesis.
6. Patients with bradyarrhythmia.
7. Asthmatic patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To compare the efficacy of dexmedetomidine nebulization and plain lignocaine so as to achieve successful airway assessment <br/ ><br>to assess the quality of airway anaesthesia <br/ ><br>to assess patient comfort score on basis of number of attempts of cough,gag reflex and hemodynamic stability. <br/ ><br> <br/ ><br>Time Points : 4weeks, 8weeksTimepoint: To compare the efficacy of dexmedetomidine nebulization and plain lignocaine so as to achieve successful airway assessment <br/ ><br>to assess the quality of airway anaesthesia <br/ ><br>to assess patient comfort score on basis of number of attempts of cough,gag reflex and hemodynamic stability. <br/ ><br> <br/ ><br>Time Points : 4weeks, 8weeks
- Secondary Outcome Measures
Name Time Method To compare patient sedation in both groups and to assess the complication if any occurs during awake fiber-optic intubation.Timepoint: To compare patient sedation by using Ramsay Sedation Score (1 to 6 Scale). <br/ ><br> <br/ ><br>Estimated i.e. at baseline, 4 weeks and 8 weeks